Canadian Anaesthetists’ Society Journal

, Volume 31, Issue 4, pp 407–415 | Cite as

Anaesthesia and emesis II: Prevention and management

  • Mark G. A. Palazzo
Review Article

Conclusion

The causes of emesis associated with anaesthesia are varied and in any one patient are likely to be multifactorial. Our approach has been to emphasise those areas which can be controlled. However, general prophylactic measures, such as reduced gastric inflation, avoidance of opiate premedication and pharyngeal stimulation, might not be sufficient to prevent emesis. Although we do not recommend routine preoperative use of antiemetics because of their relatively high incidence of side effects, we do feel there is a place for prophylaxis under certain circumstances. Our drug of choice for prophylaxis would be droperidol 0.175 mg·kg-1 intravenously, given peroperatively, although a smaller dose can be effective. For operations involving the ear we would prefer promethazine given with the premedication or peroperatively. Once nausea and vomiting have begun, cyclizine 25–50 mg intramuscularly, or one of the piperazine phenothiazines (prochlor-perazine or perphenazine), would be appropriate. In the event of the first choice drug being ineffective, we would encourage the use of a second agent, preferably one with a different site of action. We feel that familiarity with a few drugs and more attention to the controllable factors mentioned should help reduce postoperative emesis.

Key words

anaesthesia: general regional complications: emesis vomiting nausea vomiting: antiemetics 

Reference

  1. 1.
    Palazzo MGA, Strunin L. Anaesthesia and emesis. Part I: Etiology. Can Anaesth Soc J 1984; 31:178–877.PubMedGoogle Scholar
  2. 2.
    Horton RE, Ross FGM, Darling GH. Determination of the emptying time of the stomach by use of enteric coated barium granules. Br Med J 1965; 1:1537–9.PubMedGoogle Scholar
  3. 3.
    Howard JM. Gastric and salivary secretion following injury, The systemic response to injury. Ann Surg 1955; 141:342–66.PubMedGoogle Scholar
  4. 4.
    Davenport HW. Physiology of the digestive tract. 2nd Ed. Chicago: Year Book Medical Publisers Inc., 1966(165–6).Google Scholar
  5. 5.
    Margieson GR, Sorby WA, Williams HBL. The action of metoclopramide on gastric emptying. A radiological assessment. Med J Australia 1966; 2:1272–4.PubMedGoogle Scholar
  6. 6.
    James WB, Hume R. Action of metoclopramide on gastric emptying and small bowel transit time. Gut 1968; 9:203–5.PubMedCrossRefGoogle Scholar
  7. 7.
    Howarth FH, Cockel R, Roper BW, Hawkins CF. The effect of metoclopramide upon gastric motility and its value in barium progress meals. Clinical Radiology 1969; 20:294–300.PubMedCrossRefGoogle Scholar
  8. 8.
    Davies JAH, Howells TH. Management of anaesthesia for the full stomach case in the casualty department. Postgrad Med J 1973, 45, (July suppl) 58–63.Google Scholar
  9. 9.
    Holmes C. Postoperative vomiting after ether/air anaesthesia. Anaesthesia 1965; 20:199–206.PubMedCrossRefGoogle Scholar
  10. 10.
    Riding JE. The prevention of postoperative vomiting. Br J Anaesth 1963; 35:180–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Peroutka SJ, Snyder SH. Antiemetics; neuro-transmitter receptor binding predicts therapeutic actions. Lancet 1982; 1:658–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Adriana J, Summers FW, Anthony SO. Is the prophylactic use of antiemetics in surgical patients justified? JAMA 1961; 175:666–71.Google Scholar
  13. 13.
    Mirakhur RK, Dundee JW. Lack of antiemetic effect of glycopyrrolate. Anaesthesia 1981; 36:819–20.PubMedCrossRefGoogle Scholar
  14. 14.
    Wood CD. Antimotion sickness and antiemetic drugs. Drugs 1979; 17:471–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Clarke RSJ. Dundee JW, Love WJ. Studies of drugs given before anaesthesia. VIII. Morphine 10 mg alone and with atropine or hyoscine. Br J Anaesth 1965; 37:772–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Laborit H, Huguenard P, Alluaume R. Un nouveau stabilisateur vegetatif, le 4560 R P. Presse Med 1952; 60:206–8.PubMedGoogle Scholar
  17. 17.
    Paton WDM, Payne JP. Pharmacological principles and practice. London: J. and A. Churchill Ltd., 1969 (p. 117).Google Scholar
  18. 18.
    Knapp MR, Beecher HK. Postanesthetic nausea, vomiting and retching. JAMA 1956; 160:376–85.Google Scholar
  19. 19.
    Howat DDC. Antiemetic drugs in anaesthesia. Anaesthesia 1960; 15:289–97.PubMedCrossRefGoogle Scholar
  20. 20.
    Brock-Utne JG, Rubin J, Welman S, Dimopoulos GE, Moshal MG, Downing JW. The action of commonly used antiemetics on the lower oesophageal sphincter. Br J Anaesth 1978; 50:295–88.PubMedCrossRefGoogle Scholar
  21. 21.
    Loeser EA, Bennet G, Stanley TH, Machin R. Comparison of droperidol, haloperidol and prochlor- perazine as postoperative antiemetics. Can Anaesth Soc J 1979; 26:125–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Dundee JW, Assaf RAE, Loan WB, Morrison JD. A comparison of the efficacy of cyclizine and per- phenazine in reducing the emetic effects of morphine and pethidine. Br J Clin Pharm 1975; 2:81–5.Google Scholar
  23. 23.
    Ayd J Jr. A survey of drug induced extapyramidal reactions. JAMA 1961; 175:1054–60.PubMedGoogle Scholar
  24. 24.
    Shields GK, Ballinger CM, Hathaway BN. Antiemetic effectiveness of haloperidol in human volunteers challenged with apomorphine. Anesth Analg 1971; 50:1017–27.PubMedCrossRefGoogle Scholar
  25. 25.
    Tornetta F. Double blind evaluation of haloperidol for antiemetic activity. Anesth Analg 1972; 51:964–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Goodman LS, Gilman A. The pharmacological basis of therapeutics. 5th Ed. Philadelphia: Macmillan Publishing Co. Ltd., 1975 (p. 166).Google Scholar
  27. 27.
    Patton CM, Moon MR, Dannemiller FJ. The prophylactic antiemetic effect of droperidol. Anesth Analg 1974; 53:361–4.PubMedGoogle Scholar
  28. 28.
    Iwamoto K, Schwartz H. Antiemetic effect of droperidol after ophthalmic surgery. Arch Ophthalmol 1978; 96:1378–9.PubMedGoogle Scholar
  29. 29.
    Korttila K, Kauste A, Auvinen J. Comparison of domperidone and metoclopramide in the prevention and treatment of nausea and vomiting after balanced general anaesthesia. Anesth Analg 1979; 58:396–400.PubMedCrossRefGoogle Scholar
  30. 30.
    Rita L, Goodarzi M, Seleny F. Effect of low dose droperidol on postoperative vomiting in children. Can Anaesth Soc J 1981; 28:259–62.PubMedCrossRefGoogle Scholar
  31. 31.
    Bovet D, Horclois R, Walthert F. Proprietes anti- histaminiques de la N-p-methoxybenzyl-N-dimethylaminoethyl alpha amino-pyridine. Cr Seanc Soc Biol 1944; 1938:99–100.Google Scholar
  32. 32.
    Bonica JJ, Crepps W, Monk B, Bennett B. Post- anesthetic nausea retching and vomiting. Anesthesiology 1958; 19:532–40.PubMedCrossRefGoogle Scholar
  33. 33.
    Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS. Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic. Drugs 1982; 24:360–400.PubMedCrossRefGoogle Scholar
  34. 34.
    Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS. Metoclopramide: A review of its pharmacological properties and clinical use. Drugs 1976; 12:81–131.PubMedCrossRefGoogle Scholar
  35. 35.
    Shah ZP, Wilson J. An evaluation of metoclopramide as an antiemetic in minor gynaecological surgery. Br J Anaesth 1972; 44:865–7.PubMedCrossRefGoogle Scholar
  36. 36.
    Ellis FR, Spence AA. Clinical trials of metoclopramide as an antiemetic in anaesthesia, Anaesthesia 1970;25:368–71.PubMedCrossRefGoogle Scholar
  37. 37.
    Assaf RAE, Clarke RSJ, Dundee JW, Samuel IO. Studies of drugs given before anaesthesia. XXIV: Metoclopramide with morphine and pethidine. Br J Anaesth 1974;46:514–9.PubMedCrossRefGoogle Scholar
  38. 38.
    Clarke MM, Storrs JA. The prevention of postoperative vomiting after abortion; Metoclopramide. BrJ Anaesth 1969; 41:890–2.CrossRefGoogle Scholar
  39. 39.
    Tornetta FJ. Clinical studies with the new antiemetic metoclopramide. Anesth Analg 1969; 48:198–204.PubMedGoogle Scholar
  40. 40.
    Handley AJ. Metoclopramide in the prevention of postoperative nausea and vomiting, Br J Clin Practice 1967; 21:460–22.Google Scholar
  41. 41.
    Cooke RD,Comyn DJ, Ball RW. Prevention of postoperative nausea and vomiting by domperidone. S Afr Med J 1979; 56:827–9.PubMedGoogle Scholar
  42. 42.
    Wilson DB, Dundee JW. Evaluation of the antiemetic action of domperidone. Anaesthesia 1979; 34:765–77.PubMedCrossRefGoogle Scholar
  43. 43.
    Fragen RJ, Caldwell N. A new benzimidazole antiemetic, domperidone, for the treatment of postoperative nausea and vomiting. Anesthesiology 1978; 49:289–90.PubMedCrossRefGoogle Scholar
  44. 44.
    Zegveld C, Knape H, Smiths J et al. Domperidone in the treatment of postoperative vomiting: A double blind multicentre study. Anesth Analg 1978; 57:700–3.PubMedCrossRefGoogle Scholar
  45. 45.
    Boghaert A, Carron D, Gallant J, Stockman A. Postoperative vomiting treated with domperidone. A double blind comparison with metoclopramide and a placebo. Acta Anaesth Belgica 1980; 31:129- 37.Google Scholar
  46. 46.
    Fragen RJ, Caldwell N. Antiemetic effectiveness of intramuscularly administered domperidone. Anesthesiology 1979; 51:460–1.PubMedCrossRefGoogle Scholar
  47. 47.
    Maher J. Intravenous lorazepam to prevent nausea and vomiting associated with cancer chemotherapy. Lancet 1981; 1:91–2.PubMedCrossRefGoogle Scholar
  48. 48.
    Friedlander M, Kearsley JH, Tattersall MHN. Oral lorazepam to improve tolerance of cytotoxic therapy. Lancet 1981; 1:1316–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Sallan SE, Zinberg NE, Frei E. Antiemetic effects of delta 9 tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 1975; 293:795–7.PubMedGoogle Scholar
  50. 50.
    Lucas VS, Laszlo J. Delta 9 tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy. JAMA 1980; 243:1241–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Einhorn LH,Nagy C, Furnas B, Williams SD. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy. J Clin Pharmacol 1981; 21:64S-9S.PubMedGoogle Scholar
  52. 52.
    Sweet D. Marijuana for drug induced nausea and vomiting. JAMA 1980; 243:1265.PubMedCrossRefGoogle Scholar

Copyright information

© Canadian Anesthesiologists 1984

Authors and Affiliations

  • Mark G. A. Palazzo
    • 1
  1. 1.Department of AnaesthesiaFoothills Hospital, at the University of CalgaryCalgary
  2. 2.Nuffield Dept of AnaesthesiaJohn Radcliffe HospitalHeadingtonEngland

Personalised recommendations